ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth

Open Ended Schemes(Other Scheme - Index Funds)Very High Riskvs Nifty Pharma IndexISIN INF109KC11M9

NAV · 06-Jul-2026

₹19.9998

+6.93%

+13.03%

1Y (CAGR)

+16.16%

3Y (CAGR)

+23.51%

5Y (CAGR)

—

Since inception (CAGR)

+21.61%

NAV history

hover for values

Risk & SIP analytics

Q1 · TOP · 3Y in category

Volatility (3y)

15.09%

Downside dev (3y)

10.26%

Max drawdown (3y)

-16.6%

Sharpe (3y)

1.13

SIP XIRR (3y)

+16.76%

Calendar-year returns

2023 +32.9%2024 +38.8%2025 -2.6%

Vs benchmark — Nifty 50

3y monthly · 36 months of overlap

Beta

0.66

Alpha (p.a.)

+12.67%

Up capture

110.0%

Down capture

39.1%

Correlation

0.57

Fund facts

Fund managerNishit Patel · Ashwini Bharucha · Venus Ahuja

AUM₹1,302 Cr

Expense ratio0.32% · 2026-05-31

TER · AMFI officialDirect 0.50% · Regular 1.17% (2026-06-30)

Launch date25-Nov-2022

Plan typeOpen Ended · Others

Min lumpsum₹1,000

Min SIP₹1,000

Lock-inNone

Volatility14.57

AMCICICI Prudential Asset Management Company Limited

Objective · The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.

scheme documents ↗